SEC Filing Summary

August J. Troendle, President & CEO of Medpace Holdings, Inc., reported a sale of 650 shares of Common Stock on August 27, 2026. The shares were sold at a weighted average price of $620.27, with individual sales ranging from $620.00 to $621.28. This transaction was executed as a limit order during an open window period. Following this transaction, Mr. Troendle directly owns 539,894 shares. Additionally, he may be deemed to indirectly beneficially own 4,733,019 shares held by Medpace Investors, LLC, where he serves as the sole manager and controlling unit holder. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.